CRISPR Technology Market to Reach USD 11.23 Billion by 2030; Rapid Growth in Biomedical and Agricultural Applications Driving 19.89% CAGR

Introduction: Unlocking the Genetic Code with Precision

The CRISPR technology market is projected to grow from USD 4.53 billion in 2025 to USD 11.23 billion by 2030, reflecting a strong compound annual growth rate (CAGR) of 19.89%. This surge is powered by increasing demand across biomedical, agricultural, and industrial domains. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) has emerged as a critical tool for genome editing, enabling researchers and developers to precisely alter genetic material in living organisms.

This advancement in gene editing has widespread implications-not just in treating previously incurable genetic disorders, but also in improving agricultural yields and developing sustainable biotechnological applications. From targeted cancer therapies to climate-resilient crops, CRISPR's impact continues to expand.

Report Overview: https://www.mordorintelligence.com/industry-reports/crispr-technology-market---growth-trends-and-forecast-2019---2024?utm_source=openpr

Key Trends Driving CRISPR Market Expansion

1. Expanding Therapeutic Applications

A significant driver of market growth is the increasing use of CRISPR in disease treatment. In oncology, CRISPR has been used to modify immune cells to better recognize and combat solid tumors. According to a 2022 Nature study, this represents a promising direction for cancer immunotherapy. Additionally, CRISPR is being explored for its potential to correct mutations in inherited conditions like sickle cell anemia and Huntington's disease.

2. Growing Research Funding and Institutional Support

Institutions like Yale School of Medicine have received considerable funding (e.g., a $40 million NIH grant in 2023) to explore CRISPR's capabilities in treating neurogenetic disorders. Similarly, private companies are opening advanced CRISPR-focused facilities, such as Synthego's 18,000 sq. ft. GMP synthesis center, which underscores growing investment in CRISPR therapeutics and diagnostics.

3. Integration into Cardiovascular and Infectious Disease Research

Beyond rare diseases, CRISPR is being incorporated into research models for common health challenges. In cardiovascular studies, it has helped develop animal models that reflect human disease pathways. It is also being applied in diagnostics, as shown by recent innovations allowing for non-invasive cancer detection using blood samples.

CRISPR Technology Market Segmentation: Broad Application Across Sectors

By Product:

- Enzymes (38% market share in 2024): Widely used in research, particularly CRISPR-Cas9 for precise genome editing.
- Kits & Reagents: Fastest-growing segment (21% CAGR) due to demand for efficient and easy-to-use gene editing solutions.
- Guide RNA and Others (plasmids, blockers, primers): Essential for system specificity and functional expansion.

By Application:

- Biomedical (88% market share): Encompasses genetic disorder treatment, drug discovery, regenerative medicine, and cancer therapy.
- Agricultural: Fastest-growing application area, supporting disease-resistant, nutrient-enriched, and climate-resilient crops.
- Industrial and Others: Includes microbial strain engineering and energy-related applications like biofuel production.

By End User:

- Pharmaceutical and Biotechnology Companies (48% market share): Leading use cases in therapeutic development and drug discovery.
- Academic and Government Research Institutes: Fastest growth (21% CAGR) due to rising funding and collaborative projects.
- CROs and Others: Provide outsourced CRISPR services, essential for smaller biotech firms and research labs.

Explore Our Full Library of Healthcare Research Industry Reports: https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr

CRISPR Technology Market Key Players:

The CRISPR technology market is shaped by a mix of global conglomerates and niche gene-editing specialists. Companies like

- Thermo Fisher Scientific,
- Merck KGaA,
- Danaher Corporation,
- PerkinElmer, and
- GenScript

are heavily investing in new tools and product portfolios. These players are focusing on providing high-specificity Cas enzymes, complete CRISPR kits, and custom guide RNA services.

Strategic investments are another hallmark of the industry. Pfizer's $25 million investment in Caribou Sciences to advance CRISPR-based CAR T-cell therapy is one example of growing confidence in commercial viability. Additionally, service-focused providers such as Synthego are building partner ecosystems to accelerate drug discovery through integrated workflows.

The market shows signs of consolidation, with larger firms acquiring smaller CRISPR startups to enhance capabilities and secure intellectual property. However, smaller players continue to carve out space by focusing on novel applications and cost-effective solutions, particularly in diagnostic and agricultural sectors.

Conclusion: A Promising Horizon for CRISPR

The CRISPR technology market is poised for rapid growth, with applications reaching far beyond initial expectations. As precision medicine gains traction, CRISPR stands at the core of therapies for genetic disorders, cancer, and neurological diseases. Its role in agriculture-especially as the climate crisis demands more resilient crops-adds another layer of relevance.

Market expansion is reinforced by strategic funding, institutional collaborations, and product innovations. With a forecasted value of USD 11.23 billion by 2030, CRISPR technology is not just a research tool, but a foundational component of future healthcare, food security, and industrial biotechnology solutions.

As regulatory frameworks become clearer and technological barriers are addressed, the market is likely to see more real-world applications reach clinical and commercial stages, ultimately bringing the benefits of gene editing to a broader global population.

Industry Related Reports

Spatial Genomics and Transcriptomics Market - The Spatial Genomics and Transcriptomics Market is Segmented by Technology (Spatial Transcriptomics and Spatial Genomics), Product (Instruments, Software, and Consumables), End-User (Pharmaceutical Manufacturer, Diagnostic Customers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Get More Insights: https://www.mordorintelligence.com/industry-reports/spatial-genomics-and-transcriptomics-market?utm_source=openpr

Transcriptomics Market - The Transcriptomics Market report segments the industry into By Technology (Microarray, Real-time Quantitative Polymerase Chain Reaction (Q-PCR), Sequencing Technologies), By Product (Consumables, Instruments, Other Products), By Application (Diagnostics and Disease Profiling, Drug Discovery, Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, South America).

Get More Insights: https://www.mordorintelligence.com/industry-reports/transcriptomics-market?utm_source=openpr

Consumer Genomics Market - The Consumer Genomics Market report segments the industry into Application (Genetic Relatedness, Diagnostics, Lifestyle, Wellness, & Nutrition, Ancestry, Personalized Medicine & Pharmacogenetic Testing, Sports Nutrition & Health, Other Application Types), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). Get five years of historical data alongside five-year market forecasts.

Get More Insights: https://www.mordorintelligence.com/industry-reports/consumer-genomics-market--growth-trends-and-forecast?utm_source=openpr

Genomics Market - The Genomics Market report segments the industry into By Product And Services (Consumables, Systems And Software, Services), By Techniques (PCR, Sequencing, Microarray, Nucleic Acid Extraction And Purification, and more), By Application (Diagnostics, Drug Discovery And Development, Precision Medicine, and more), By End User (Hospitals And Clinics, Research Centers, and more), and Geography.

Get More Insights: https://www.mordorintelligence.com/industry-reports/genomics-market?utm_source=openpr

3D Printing in Healthcare Market- The Healthcare 3D Printing Market report segments the industry into By Technology (Stereo Lithography, Deposition Modeling, Electron Beam Melting, Laser Sintering, Jetting Technology, Laminated Object Manufacturing, and more), By Application (Medical Implants, Prosthetics, Wearable Devices, and more), By Material (Metal and Alloy, Polymer, and more), and Geography (North America, Europe, Asia-Pacific, and more).

Get More Insights: https://www.mordorintelligence.com/industry-reports/global-3d-printing-market-in-healthcare-industry-industry?utm_source=openpr

For any inquiries or to access the full report, please contact: media@mordorintelligence.com https://www.mordorintelligence.com/ Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli.
Hyderabad, Telangana, India 500032

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

This release was published on openPR.